Filing Flows › DexCom (DXCM) › Guidance & outlook

DexCom (DXCM) guidance and outlook

DexCom (DXCM) raised its guidance on Oct 29, 2026: Revenue $5.2B for FY2026; Revenue +12% to +13% for FY2026; Gross margin 64% for FY2026; Operating margin 24% for FY2026.

Guidance and outlook

Met or beat 2 of 2 guided periods. Grey: the last range guided before the figures came out; dot: the reported figure.

Latest guidance

Metric	Period	Range	Change
Revenue	FY2026	$5.2B	reaffirmed
Revenue	FY2026	+12% to +13%	raised
Gross margin	FY2026	64%	reaffirmed
Operating margin	FY2026	24%	raised
EBITDA margin	FY2026	32%	raised

From the earnings release filed Oct 29, 2026 (8-K on EDGAR).

DexCom's latest quarter

DexCom, Q3 2026: revenue $1.3B (+11% year over year), operating margin 24.3%, net earnings $275M, operating cash flow $326M. The chart follows the revenue to costs, profit and cash.

Questions

Did DexCom raise or lower its guidance?

DexCom (DXCM) raised its guidance on Oct 29, 2026: Revenue $5.2B for FY2026; Revenue +12% to +13% for FY2026; Gross margin 64% for FY2026; Operating margin 24% for FY2026.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.